17-4785622-C-G

Variant summary

Our verdict is Uncertain significance. Variant got 1 ACMG points: 2P and 1B. PM2BP4

The ENST00000328739.6(VMO1):ā€‹c.349G>Cā€‹(p.Gly117Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000744 in 1,612,258 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā˜…).

Frequency

Genomes: š‘“ 0.0000066 ( 0 hom., cov: 33)
Exomes š‘“: 0.0000075 ( 0 hom. )

Consequence

VMO1
ENST00000328739.6 missense

Scores

1
3
15

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 0.275
Variant links:
Genes affected
VMO1 (HGNC:30387): (vitelline membrane outer layer 1 homolog) Located in extracellular exosome. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Uncertain_significance. Variant got 1 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.321823).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
VMO1NM_182566.3 linkuse as main transcriptc.349G>C p.Gly117Arg missense_variant 3/3 ENST00000328739.6 NP_872372.1 Q7Z5L0-1
VMO1NM_001144939.2 linkuse as main transcriptc.*40G>C 3_prime_UTR_variant 3/3 NP_001138411.1 Q7Z5L0-4
VMO1NM_001144940.2 linkuse as main transcriptc.*20G>C 3_prime_UTR_variant 3/3 NP_001138412.1 Q7Z5L0-3
VMO1NM_001144941.2 linkuse as main transcriptc.*20G>C 3_prime_UTR_variant 2/2 NP_001138413.1 Q7Z5L0-2

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
VMO1ENST00000328739.6 linkuse as main transcriptc.349G>C p.Gly117Arg missense_variant 3/31 NM_182566.3 ENSP00000328397.5 Q7Z5L0-1
VMO1ENST00000354194.4 linkuse as main transcriptc.*20G>C 3_prime_UTR_variant 2/21 ENSP00000346133.4 Q7Z5L0-2
VMO1ENST00000441199.2 linkuse as main transcriptc.*40G>C 3_prime_UTR_variant 3/32 ENSP00000408166.2 Q7Z5L0-4
VMO1ENST00000416307.6 linkuse as main transcriptc.*20G>C 3_prime_UTR_variant 3/32 ENSP00000390450.2 Q7Z5L0-3

Frequencies

GnomAD3 genomes
AF:
0.00000657
AC:
1
AN:
152264
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.000193
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.0000282
AC:
7
AN:
248400
Hom.:
0
AF XY:
0.0000371
AC XY:
5
AN XY:
134650
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.000382
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.00000753
AC:
11
AN:
1459994
Hom.:
0
Cov.:
30
AF XY:
0.0000110
AC XY:
8
AN XY:
726384
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.0000756
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.00000719
Gnomad4 OTH exome
AF:
0.00
GnomAD4 genome
AF:
0.00000657
AC:
1
AN:
152264
Hom.:
0
Cov.:
33
AF XY:
0.00
AC XY:
0
AN XY:
74394
show subpopulations
Gnomad4 AFR
AF:
0.00
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.000193
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.00
Gnomad4 OTH
AF:
0.00
Bravo
AF:
0.00000756
ExAC
AF:
0.0000330
AC:
4

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsMar 25, 2024The c.349G>C (p.G117R) alteration is located in exon 3 (coding exon 3) of the VMO1 gene. This alteration results from a G to C substitution at nucleotide position 349, causing the glycine (G) at amino acid position 117 to be replaced by an arginine (R). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.14
BayesDel_addAF
Benign
-0.33
T
BayesDel_noAF
Benign
-0.40
CADD
Benign
8.6
DANN
Uncertain
0.99
DEOGEN2
Benign
0.034
T
Eigen
Benign
-0.49
Eigen_PC
Benign
-0.55
FATHMM_MKL
Benign
0.28
N
LIST_S2
Benign
0.55
T
M_CAP
Benign
0.030
D
MetaRNN
Benign
0.32
T
MetaSVM
Benign
-0.96
T
MutationAssessor
Pathogenic
2.9
M
MutationTaster
Benign
0.92
D;D;D;D
PrimateAI
Benign
0.36
T
PROVEAN
Uncertain
-3.9
D
REVEL
Benign
0.095
Sift
Benign
0.039
D
Sift4G
Uncertain
0.0030
D
Polyphen
0.46
P
Vest4
0.25
MutPred
0.77
Gain of MoRF binding (P = 0.0482);
MVP
0.41
MPC
0.77
ClinPred
0.43
T
GERP RS
3.0
Varity_R
0.30
gMVP
0.76

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs767585512; hg19: chr17-4688917; API